Top Markets
#1 MowCat MowCat +48.45%
#2 Bermuda Shorts Bermuda Shorts +31.49%
#3 Biconomy Biconomy +22.77%
#4 Velvet Velvet +21.04%
#5 Derive Derive +17.92%
#6 MarsCoin MarsCoin +17.75%
#7 Quack AI Quack AI +17.33%
#8 Audiera Audiera +14.23%
#9 Perle Perle +14.15%
#10 aPriori aPriori +13.82%
Coin of the day
MowCat MowCat
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Cellyan Biotechnology Co., Ltd Cellyan Biotechnology Co., Ltd

Cellyan Biotechnology Co., Ltd

HKPD
Rang in Aktien #34988
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily... Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
Aktienkurs
$0.422
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$4.63M
Veränderung (1 Tag)
0.48%
Veränderung (1 Jahr)
-60.56%
Land
HK
Handel Cellyan Biotechnology Co., Ltd (HKPD)

Kategorie

Healthcare
P/S-Verhältnis für Cellyan Biotechnology Co., Ltd (HKPD)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Cellyan Biotechnology Co., Ltd beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Cellyan Biotechnology Co., Ltd von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.24 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
14.89 -
US